Hepatitis C in pregnant women in Xi'an
Part of Digestive system, Infections clinical trials.
This study looks at how common Hepatitis C virus infection is in pregnant women in Xi'an, China, and how it changes over time. It may help doctors better understand and care for pregnant women with Hepatitis C.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant or have just given birth (confirmed by a blood test).
- You are 18 years old or older.
- You tested positive for Hepatitis C antibodies or the virus itself between 2014 and 2023.
- You have a valid phone number where we can reach you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows pregnant women with a viral infection (like COVID-19, HIV, or hepatitis) and their children to learn how the infection affects both. It helps doctors better understand and care for families during and after pregnancy.
This trial is a screening study to find hepatitis B and C infections in the Chinese community in Milan. It involves a simple rapid blood test and a questionnaire to help improve awareness and prevention.
This study tests a medicine called glecaprevir/pibrentasvir for pregnant women with hepatitis C, with or without HIV. It aims to see how the medicine works in the body and if it is safe during pregnancy.
This study is a pregnancy registry that collects information about people who have hepatitis C during pregnancy and took hepatitis C medicines early in pregnancy. It aims to better understand the safety and outcomes of treatment around conception.
This study tests whether treating hepatitis C during pregnancy is feasible and acceptable for pregnant women who have a history of drug use. If you qualify, you may receive treatment that could help protect your health and your baby's health.
This study compares two antiviral medications (TAF and TDF) in pregnant women with hepatitis B to see which is safer and more effective during pregnancy and for the baby's health.
Hear when a new HCV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.